Skip to main content
Elizabeth Gillies, MD, Pathology, Oklahoma City, OK

ElizabethMGilliesMD

Pathology Oklahoma City, OK

Anatomic Pathology, Clinical Pathology

Assistant Professor, Pathology (Clinical), University of Oklahoma College of Medicine

Are you Dr. Gillies?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 32 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    940 Stanton L Young Blvd
    Ste 451
    Oklahoma City, OK 73104
    Phone+1 405-271-2422
    Fax+1 405-271-3064

Summary

  • Dr. Elizabeth Gillies, MD is a board certified pathologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma and Utah. She is affiliated with Oklahoma City VA Medical Center, OU Health, and OU Medical Center Edmond.

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterResidency, Pathology-Anatomic and Clinical, 1991 - 1995
  • University of Santo Tomas
    University of Santo TomasClass of 1979

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 1992 - 2024
  • UT State Medical License
    UT State Medical License 1992 - 1994
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Publications & Presentations

PubMed

Press Mentions

  • Welcome to Our Biomacromolecules New Associate Editors
    Welcome to Our Biomacromolecules New Associate EditorsJune 8th, 2020
  • Devonian Health Group Announces the Formation of a Scientific Advisory Board with Mandate to Assist in the Development of Cannabinoïds-Based Pharmaceutical Products
    Devonian Health Group Announces the Formation of a Scientific Advisory Board with Mandate to Assist in the Development of Cannabinoïds-Based Pharmaceutical ProductsOctober 3rd, 2019